Table 1 Study population characteristics.
n | 1349 | |
---|---|---|
Women | Age, years (mean, min‒max) | 31.0 (18‒48) |
Country of birth within EU, n (%) | 1235 (91.5) | |
BMI at first antenatal visit, kg/m2 (mean ± SD) | 28.5 ± 6.0 | |
Nulliparous, n (%) | 552 (40.9) | |
Smoking at first antenatal visit, n (%) a | 89 (6.8) | |
Asthma, n (%) | 132 (9.8) | |
Inflammatory bowel disease, n (%) | 10 (0.7) | |
Hypertension, n (%) | 9 (0.7) | |
Hypothyroidism, n (%) | 37 (2.7) | |
Diabetes mellitus, n (%) | 2 (0.1) | |
Epilepsy, n (%) | 13 (1.0) | |
Rheumatic disease, n (%) | 2 (0.1) | |
Renal disease, n (%) | 5 (0.4) | |
Gestational diabetes, n (%) | 24 (1.8) | |
Gestational hypertension, n (%) | 56 (4.2) | |
Preeclampsia, n (%) | 27 (2.0) | |
Infants | Female, n (%) | 650 (48.2) |
Birth weight, g (mean ± SD) | 3684 ± 494 | |
LGA, n (%) | 168 (12.5) | |
SGA, n (%) | 51 (3.8) | |
Gestational age at birth, days (mean ± SD) | 279 ± 8 |